; on behalf of the investigators of the TransLineE project { Objective: To collect (i) baseline data and (ii) execute a large multicentre study examining the effect of trans a-linolenic acid on its incorporation into plasma lipids and on risk factors for coronary heart disease. Design: Male volunteers were recruited and the habitual diet assessed by a 4-d weighed record. Fatty acid composition of plasma and platelet lipids were determined by gas chromatography at baseline. After a 6 week run-in period on a trans`free' diet, male volunteers were randomised to consume 0.6 % of energy trans a-linolenic acid or to continue with a diet`low' in trans a-linolenic acid for 6 weeks. Setting: Three European university research departments supported by the research and development departments of the food industry. Subjects: Male volunteers (88) recruited by local advertisement. Methods: Replacement of 30 % of the fat of the habitual diet by margarine, oil and foods. Rapeseed oil was deodorised especially to produce the trans`free' and`high' trans foods for this study. The incorporation and conversion of trans a-linolenic acid into plasma lipids and platelets was assessed by gas chromatography and dietary compliance was veri®ed by 4-d weighed record. Results: Less trans a-linolenic acid isomers are incorporated into human plasma lipids in French volunteers than in Dutch or Scottish volunteers consuming their habitual diets. Trans`free' a-linolenic acid-rich oil can be produced by careful deodorization during re®ning. The`high' trans diet provided 1410AE 42 mg/d trans isomers of a-linolenic acid, whilst the`low' trans group consumed 60 AE 75 mg/d. The change in plasma lipid and platelet fatty acid composition documented that trans linolenic isomers are incorporated and converted to a trans isomer of eicosapentaenoic acid. Only the 15-trans a-linolenic acid is incorporated into plasma cholesteryl esters. The group consuming low trans diet had a slightly higher intake of fat, especially saturated and monounsaturated fat. Conclusions: Trans`free' rapeseed oil, rich in a-linolenic acid, can be produced by careful deodorization. Dietary records show good compliance. Dietary trans isomers of a-linolenic acid are incorporated in plasma lipids and converted to long-chain polyunsaturated fatty acids. Their effects on risk factors for coronary heart disease and their metabolism will be reported elsewhere. Sponsorship: European Commission (FAIR 95-0594 grant).
Introduction
Dietary trans isomers of mono-unsaturated fatty acids, formed during partial hydrogenation of edible oils or by intestinal fermentation in ruminants, have been linked with an increased risk of coronary heart disease (Thomas et al, 1992; Willett et al, 1993; Ascherio et al, 1996; Hu et al, 1997) . This is perhaps due to the fact that trans monoenoic fatty acids when compared with cis monoenoic fatty acids raise serum low density lipoprotein and reduce high density lipoprotein cholesterol (Mensink & Katan, 1993) . The relative amount of trans fatty acids in adipose tissue and plasma phospholipids, arguably a measure of the average intake, has not been associated with an increased risk of coronary heart disease (Aro et al, 1995; Roberts et al, 1995; van de Vijver et al, 1996) and some of the reasons for the contradictory results have been discussed (McKeigue, 1995; Hu et al, 1997; Aro, 1998) .
Trans isomers of polyunsaturated fatty acids are formed during deodorization of edible oils and numerous animal studies have shown that isomers of linoleic and linolenic acids are incorporated in rat tissues (Se Âbe Âdio & Chardigny, 1998). 9t, 12c, 15c-, 9c, 12t, 15c-and 9c, 12c , 15t-alinolenic acid are converted by successive desaturations and elongation into trans isomers of eicosapentaenoic acid (20 : 5 n-3) (Grandgirard et al, 1989; Chardigny et al, 1996b) and compete with a-linolenic acid (18 : 3 n-3) at the D6 desaturation step . Dietary trans 18 : 3 n-3 fatty acids can also inhibit the D 5 desaturase and hence the biosynthesis of arachidonic acid (20 : 4 n-6) (Blond, 1990) . Trans isomers of n-3 fatty acids with 20 or 22 carbon atoms occur in up to 1 % of fatty acids in all examined tissues, including the liver and the heart of the rat (Grandgirard et al, 1989) .
Much less is known about the metabolism of dietary trans polyunsaturated fatty acids in man. Human platelets do contain small amounts of these trans isomers of 20 : 5 n-3 and docosahexaenoic acid (22 : 6 n-3) (Chardigny et al, 1993) . Trans isomers of 18 : 3 n-3 occur in human serum (Wolff, 1995) and maternal milk (Chardigny et al, 1995; Chen et al, 1995) . This is not surprising since trans polyunsaturated fatty acids are found in heated vegetable oils and in numerous human food items (Chardigny et al, 1996a) , such as low calorie spreads (Wolff & Se Âbe Âdio, 1994) and infant formulas (O'Keefe et al, 1994; Chardigny et al, 1996c; Ratnayake et al, 1997) . The average intake of trans 18 : 3 n-3 in European men and women is not precisely known (because of dif®culties separating trans 18 : 3 n-3 and 20 : 1 by capillary gas chromatography in some laboratories). Nevertheless, the intake of the sum of these two isomers is low in comparison to trans isomers of 18 : 1 (Transfair, 1998) and data from Canadian women supports this view (Chen et al, 1995) . As much as 50 % of a-linolenic acid could be in the trans form (Chen et al, 1995) , suggesting the intake of trans 18 : 3 n-3 is likely to increase if more a-linolenic acid would be consumed to prevent coronary heart disease (up to 1 % of energy) as advised by an expert committee (De Deckere et al, 1998) .
In view of these changing trends it is imperative to collect baseline data concerning trans fatty acids in plasma lipids and platelets and to study the effects of a diet low or high in trans a-linolenic acid (TransLinE; trans a-linolenic acid in Europe).
Materials and methods

Design
The aim of this part of the project 1 in three European centres: Clermont-Ferrand (France), Edinburgh (Scotland) and Maastricht (the Netherlands) was to assess the effect of trans a-linolenic acid on risk factors for coronary heart disease in male volunteers. The study was designed as a double blind intervention trial in which 30 % of the fat of the habitual diet was replaced by foods prepared with the experimental fats and oils. Trans fatty acids in the diet, plasma lipids and platelets vary between European countries (Table 1 ). The in¯uence of the background diet was minimised by asking volunteers to reduce the consumption of foods containing trans fatty acids (both monounsaturated and polyunsaturated trans fatty acids) as much as possible for the duration of the entire project. Consequently, the intake of ruminant meat, cheese (except goat cheese: low in trans), as well as foods containing hydrogenated fats, were avoided and their usual oil was replaced by a specially re®ned canola oil (see below). In all other aspects, the participants were encouraged to continue their normal lifestyle and physical activity. The men gave informed consent, and approval had been obtained from the three local ethical committees.
A parallel design comparing`low' trans and`high' trans a-linolenic acid in the diet was adopted (see protocol below). This was to avoid possible carry-over effects in cross-over studies with dietary fat. The aim was to consume 0.6 % of energy in the form of trans at the expense of all cis a-linolenic acid from re®ned canola oil. The total trans plus cis linolenic acid intake approximated 1.2 % of energy and the relative amount of trans a-linolenic acid was close to the highest reported values (Chen et al, 1995) .
Recruitment of volunteers
Men were recruited from a panel of registered volunteers (Clermont-Ferrand, France), or local advertisement campaigns in Edinburgh, Scotland (students and staff of the University) and in Maastricht, the Netherlands (general population). Only clinically healthy subjects with a normal energy intake, body mass index (BMI`27 kg/m 2 ) and plasma cholesterol levels (`6.5 mmol/L measured on two separated occasions at least one week apart) were enrolled. A total of 91 men entered the study: 32 in Clermont-Ferrand, (16 during the spring and 16 during the autumn of 1996). 28 in Edinburgh (all during the spring of 1996) and 31 in Maastricht (all during the autumn of 1996). Thirty-one subjects completed the study in Clermont-Ferrand, whereas 26 subjects completed the study in Edinburgh. All the 31 volunteers completed the study in Maastricht. The French dropout used anti-in¯ammatory medication interfering with the protocol and the two who dropped out in Edinburgh found the constraints of the study too hard. Baseline characteristics of the subjects at entry did not differ between the centres, except for a small difference in systolic blood pressure and smoking habits ( Table 2) . The difference in these smoking habits was due to the fact that the target of 40 % smokers was reached only in Clermont-Ferrand.
Preparation of experimental oils
The technology for the preparation of the experimental oils and fats, low or high in trans a-linolenic acid, had to be developed for this project (He Ânon et al, 1999) . Canola oil (360 kg) containing 11.9 % of 18 : 3 n-3 was deodorised at a low temperature (180 C) for 5 h under a blanket of nitrogen at 2± 3 mbar pressure (trans`free'). Another portion of the same batch of canola oil (350 kg) was deodorised in a pilot plant for 52.5 h at 205 C under 3 mbar pressure. These conditions were optimised to yield a high amount of trans 18 : 3 with as little trans linoleic acid (18 : 2 n-6) as possible (He Ânon et al, 1999) . Under these conditions 36.5 % of alinolenic acid was converted to the trans form. The relative amount of trans 18 : 2 n-6 rose from undetectable levels to 0.5 % of fatty acids. Therefore trans 18 : 2 n-6 was added in the form of a highly isomerised sun¯ower oil (deodorised at 270 C for 18 h) to the`trans-free' oil to arrive at the`low' trans oil. One batch of oil was rejected in the production of margarine by a tasting panel, but generally the oil had good 1 The metabolism of trans polyunsaturated fatty acids and their effect on the metabolism of linoleic acid in man and rats is also studied as part of the TransLinE project.
The TransLinE study JL Se Âbe Âdio et al sensory properties. The ®nal fatty acid composition of the mixture of ®ve batches used for the study is presented in Table 3 . Vitamin E in the form of the free alcohol was added to the`high' trans oil in order to have the same amount of tocopherols in both the`high' trans and thè low' trans oils.
These oils were used to prepare margarine, cheese, biscuits and muf®ns. In Finland (Raisio Margarinii, Raisio), margarine was prepared by mixing the oils with a hard fat component, devoid of trans fatty acids. The fat mixture consisted of 77 % of oil and 23 % of the hard fat component. The margarines contained 70 % fat and 0.5 % salt with milk protein. The fatty acid composition of the margarine is given in Table 3 . Cheese was produced from homogenised pasteurised fat free milk, lecithin and experimental oil (30 %). The ®nal fat content of the cheeses (200 g each), matured for 30 d, was 20 % (Duboz & Grappin, Poligny, France). Finally, some`chocolate¯av-oured' muf®ns and`orange¯avoured' biscuits (CRNH, Clermont-Ferrand) were produced to vary the sources of oils in the diet. These were prepared using 13.70 g margarine/100 g biscuits or cookies. In Maastricht, cheese, muf®ns and biscuits were not provided, but a fruit pie (Limburgse vlaai), cakes and biscuits prepared by a local baker using 3.93AE 1.12 4.43AE 1.10 3.56AE 1.17 * S trans 1.09AE 0.32 1.57AE 0.64 1.80AE 0.82 ** *P`0.05, **P`0.01, ***P`0.0001.
The TransLinE study JL Se Âbe Âdio et al the experimental margarines were given. All oils and food items were colour coded (yellow trans`free', orange and green for the`high' and`low' trans to maintain the doubleblind nature of the study).
Laboratory methods
The principle of centralised laboratory analyses was adopted to avoid systematic bias in results from the three countries, except that the platelet aggregation studies were carried out immediately after blood collection using a standardised method. Plasma total and HDL cholesterol and triglycerides were determined by enzymatic methods (CHOD-PAP, Monotest cholesterol, Roche, Germany; GPO-Trinder, Sigma Diagnostics, St Louis, USA) in Maastricht. Low density lipoprotein cholesterol was calculated using the Friedewald equation (Friedewald et al, 1972) . Fatty acid composition of plasma lipids was determined in Dijon. Plasma lipids were extracted according to Moilanen & Nikkari, 1981 and were separated by thin layer chromatography on precoated silica gel plates (SDS, Peypin, France). Phospholipids (remaining at the origin), triglycerides (Rf value 0.35) and cholesteryl esters (Rf 0.45) were scraped off the plates and the fatty acid methyl esters obtained by transmethylation according to Morrison & Smith, 1964 . Methyl esters were prepared by direct trans-methylation of extracted lipids from the oil, margarine, cheese and biscuit used for the study. The methyl esters were then analysed by capillary gas chromatography using Hewlett Packard 6890 GC with an automatic injector, a BPX 70 column (50 m 6 0.25 mm internal diameter, SGE, Melbourne, Australia) and a¯ame ionisation detector. The error in the determination of fatty acid methyl esters depends on the relative amount of a particular component in the sample. Thus for peaks representing b 1 % of fatty acids, the coef®cient of variation is less than 10 %. For smaller peaks of 0.2 or`0.1 % of fatty acids these errors are in the order of 40 and 100 % respectively. Fractionation of the lipid fractions by high pressure liquid chromatography could have reduced the errors, but this was not possible for this project due to the large number of samples.
Dietary analyses
The fatty acid composition of the diet (weighed record) was calculated separately for the three centres using country speci®c food tables and the composition of the experimental fats, oils and foods. The dietary record was made over 4 d including at least one weekend day. In Edinburgh Comp-Eat4 (Nutrition Systems, London, UK) was used and the fatty acid composition including trans was obtained from manufacturers, existing food tables (Foodbase, Institute of Brain Chemistry and Human Nutrition, London, UK) and laboratory analyses. However, there are still a number of foods with missing and/or doubtful trans fatty acid data. The intake of fat from these represents some 10 to 15 % of total fat consumption. In Maastricht and Clermont-Ferrand the food composition was calculated in a similar manner using the Dutch Food Composition Table (Stichting NEVO, 1993) and the`Re Âpertoire Ge Âne Âral des Aliments' in France (Favier et al, 1991) . The energy intake of trans fatty acids could not be calculated as these two food tables do not list trans fatty acid contents. The intake of trans a-linolenic acid is, however, based on the analyses of the fatty acid composition of the experimental foods.
Protocol
After recruitment and analysis of their habitual diet by a 4 d weighed record, the men attended the clinic each week for the duration of the study (12 weeks) to collect food items and also to be weighed without shoes and heavy clothes. If necessary, energy intake was adjusted to maintain stable The amount of C6 : 0 to C14 : 0 in margarines ranged from 9.7 ± 10.2 % of fatty acids and did not differ between the three types.
# Trans linoleic acid added to same level as in`high' trans oil or margarine.
The TransLinE study JL Se Âbe Âdio et al body weight. On the ®rst visit, the men attended in the fasting state (from at least 22 : 00 h), blood pressure (after 5 min rest) was recorded before the collection of blood samples (EDTA) for the analysis of plasma lipids and lipoproteins. A large needle (1.2 mm diameter; Strausz cannula, Su Èddeutsche Feinmechanik, D6480 Wa Èchters-bach, Germany) was used without stasis and the ®rst 5 ml blood discarded. In addition a large volume of citrated blood (100 ml) was collected for the isolation of platelets. Aliquots were stored for the analysis of fatty acid composition of plasma and platelets. All men then were instructed how to avoid foods containing trans fatty acids and consumed foods prepared with trans`free' rapeseed oil or margarine for a period of 6 weeks (run-in). Blood samples for lipids were collected again at weeks 3, 5 and 6. A second large blood sample was collected to isolate platelets at week 6 (Figure 1 ). Blood pressure measurement was repeated and a second 4-d dietary record was made during the week 6. The men strati®ed by age, BMI and smoking in the three cities, were then randomly allocated to either a`low' trans or`high' trans diet by the Edinburgh centre using Excel spread sheet (Microsoft Of®ce, USA). The test period lasted six weeks and all measurements and blood sampling after overnight fast were repeated at identical intervals as described for the run-in period. During week 12 a third and ®nal 4-d weighed dietary record was made (Figure 1 ).
Statistical methods
Differences between centres were tested by w 2 or MannWhitney tests and differences between the randomised treatment groups after the test period were tested by analysis of covariance adjusted for the level of the corresponding measurement at the end of the ®rst six weeks on a trans`free' diet (run-in period).
Results
Plasma and platelet fatty acid composition during habitual diet Trans isomers of individual fatty acids and the total amount of trans fatty acids in plasma lipids differed between the three countries. The relative amounts of trans linolenic acid in plasma triglycerides and phospholipids were higher in Maastricht and Edinburgh than in Clermont-Ferrand. The relative amounts of cis a-linolenic acid in plasma lipids and platelets showed similar trends: similar values in Dutch and Scottish and lower levels in the French volunteers (Table 1) . Only traces of trans a-linolenic acid were found in platelet membranes. Despite this, slightly higher amounts of trans eicosapentaenoic acid were observed in platelet membranes of Dutch and French volunteers ( Table 1 ). The levels of total trans fatty acids were higher in plasma triglycerides than in cholesteryl-esters or phospholipids. As expected the major trans fatty acids in plasma triglycerides, phospholipids and platelets were trans monoenoic fatty acids (trans 18 : 1). Only in the cholesteryl ester fraction were the relative amounts of trans isomers from linoleic and linolenic acid higher or similar to those of trans 18 : 1.
Nutrient intake in the intervention trial First careful, low temperature deodorization of a canola oil containing some 12.4 % a-linolenic acid did not result in trans a-linolenic acid ( $ 0.1 % of fatty acids). Almost 40 % of a-linolenic acid was isomerised during the production of the high trans canola oil.
Eighty-eight volunteers completed the dietary intervention trial. At the end of the run-in period, when all the volunteers had been consuming a trans`free' diet for 6 weeks, the nutrient intake did not differ between the two groups assigned to the`low' or`high' trans diet for the next Figure 1 The schematic diagram of the protocol of the human feeding study. The double-blind feeding study comprised two successive periods of 6 weeks. After the ®rst run-in period (0 ± 6 weeks), when all subjects consumed a trans`free' diet, the volunteers were randomly switched to a`low' or à high' trans a-linolenic acid diet (0.6 % of energy) for the second 6 week period. Small arrows denote fasting blood samples for lipids (and haemostatic factors), whilst big arrows denote a larger blood sample that allowed also platelet fatty acid composition (and function) to be determined. Hatched bar indicates a 4-d weighed dietary record in that week.
The TransLinE study JL Se Âbe Âdio et al 6 weeks. The average intake of fat was in the order of 35 % of energy and contained little trans fatty acids (Table 4) . After 6 weeks on the`high' trans diet, the intake of trans a-linolenic acid increased some 20-fold, but did not change in the group consuming the`low' trans diet (Table 4) . These changes in trans a-linolenic acid intake did not differ signi®cantly between the three centres (not shown). The intake of fat, particularly of saturated and monounsaturated fat increased slightly in the group on the`low' trans diet, whereas there was the opposite trend in the`high' trans group. The difference was signi®cant for the total, saturated and monounsaturated fat intake. The intake of energy and other nutrients did not differ between the two dietary groups.
Mean body weight of the volunteers decreased slightly in the group consuming the`low' trans diet, whereas it increased in the`high' trans group: 7 0.4 AE 1.2 vs 0.2 AE 1.1 kg. The difference between the two dietary groups was signi®cant (P`0.05) after adjustment for the initial body weight (at the end of the run-in period). Changes in body weight of volunteers consuming thè low' or`high' trans diet differed between the three centres (P`0.01). In Clermont-Ferrand both dietary groups tended to lose weight, whereas in Edinburgh and Maastricht there was a tendency to lose weight on the`low' and to gain weight on the`high' trans diet (not shown). The mean systolic and diastolic pressures varied between 120 and 124 mmHg, and 70 and 73 mmHg, respectively, without any signi®cant difference before and during the 6-week experimental period.
Changes in fatty acid composition
The changes in the cis and trans n-3 fatty acid composition were as expected.
{ The relative amount of trans a-linolenic acid increased in plasma triglyceride, phospholipid and cholesteryl ester fractions of volunteers consuming thè high' trans diet (Table 5) . Trans a-linolenic acid comprised one third of the total amount of a-linolenic acid in plasma phospholipids and cholesteryl esters. Interestingly the only trans isomer of a-linolenic acid that was incorporated in the cholesteryl ester fraction was the 9c, 12c, 15t-form (Figure 2) . At the same time the percentage of cis a-linolenic acid decreased in these fractions, except in plasma triglyceride fraction. The n-3 fatty acid composition was stable in the group consuming the`low' trans diet and the difference between the`low' and`high' trans groups was signi®cant. There was an increase in the small amount of trans eicosapentaenoic acid in plasma triglycerides, phospholipids and cholesteryl esters, but without a change in the amount of cis eicosapentaenoic acid. The relative amounts of trans isomers of oleic and linoleic acid run-in 2.0 AE 0.5 1.9AE 0.6 test period 1.9 AE 0.5 2.0AE 0.6 change 7 0.1 AE 0.5 0.1AE 0.4 {`L ow' vs`high' trans *P`0.05, **P`0.01, ***P`0.001. cis isomers only, *P`0.05, **P`0.01, ***P`0.001.
{
The fully fatty acid composition data may be obtained from the guarantor of this project (sebedio@dijon.inra.fr).
The TransLinE study JL Se Âbe Âdio et al in these fractions remained stable during the experimental dietary periods (not shown).
As expected the relative amount of trans isomers of 18 : 1 in plasma triglycerides and cholesterol esters in the volunteers consuming the trans fat`free' diet for 6 weeks decreased from 1.37 AE 0.08 to 0.97 AE 0.09 and from 0.25 AE 0.05 to 0.14 AE 0.02 % of fatty acids, respectively (both P`0.05). However the level did not decline further in the group continuing with the`low' trans diet for 6 weeks with values of 0.91 AE 0.09 and 0.11 AE 0.01 % of fatty acids respectively, nor did the levels decline in the group switched to the`high' trans diet (not shown). What is perhaps surprising is that levels of these trans isomers in plasma phospholipids never changed at all: 0.69 AE 0.04 (control), 0.63 AE 0.04 (6 weeks trans`free') and 0.59 AE 0.04 % of fatty acids (trans`free' followed by 6 weeks`low' trans).
The`high' trans diet did not in¯uence the relative amounts of n-6 polyunsaturated fatty acids linoleic, g-linolenic, dihomo-g-linolenic and arachidonic acid (not shown).
Discussion
Trans fatty acids at baseline Our results con®rm earlier observations (Aro et al, 1995; Transfair, 1998 ) that the relative amount of trans fatty acids in plasma lipids, adipose tissue or in the diet differ between European populations. Our French volunteers had lower trans 18 : 1 levels than their Dutch or Scottish counterparts and almost certainly this re¯ects the higher intake of trans fats and of hydrogenated oils in Northern Europe than in the Southern countries (Wolff & Se Âbe Âdio, 1994; Transfair, 1998) . The same geographical trend across Europe is not observed for the trans isomers of linoleic and a-linolenic acid. Trans isomers of these fatty acids are formed during the deodorization of linoleic and a-linolenic acid-rich vegetable oils at high temperatures (He Ânon et al, 1999; Wolff, 1993) . It is known that there are large variations in the relative amount of a-linolenic acid isomerised in vegetable oils (Ratnayake et al, 1997; Wolff & Se Âbe Âdio, 1994) . In fact one may think that the quantity of these trans polyunsaturated fatty acids in biological samples may Figure 2 The capillary gas chromatogram demonstrating the separation of the different trans isomers of a-linolenic acid as the methyl esters in a sample of the`high' trans oil (top panel), and of the plasma cholesteryl ester fraction of the same male volunteer at the end of a period of 6 weeks on the trans free' diet (run-in period; middle panel) and at the end of a 6 week period on the`high' trans fat diet (bottom panel). Note the absence of the 9t, 12c, 15c-isomer of a-linolenic acid in the cholesteryl ester fraction (arrow).
The identi®cation tct, cct, tcc refer to 9t, 12c, 15t-, 9c, 12c, 15t-and 9t, 12c, 15c -isomers of a-linolenic acid (ccc) respectively. g-Linolenic methyl ester peak in the cholesteryl ester fraction is labelled with 18 : 3 n-6.
The TransLinE study JL Se Âbe Âdio et al re¯ect primarily the quality, rather than the quantity of the ingested re®ned oil and ultimately they re¯ect the conditions under which the oil was re®ned. Thus if well-deodorised, the intake of trans a-linolenic acid could be negligible. What this project did show is that it is indeed possible to obtain well-re®ned oils rich in a-linolenic acid with good organoleptic properties and yet low in trans polyunsaturates.
The information about trans a-linolenic acid in foods is virtually non-existent. However, the average levels of trans a-linolenic acid in plasma lipids at baseline when compared with the increase during the experimental period when given 1.4 g/d should indicate the relative amount consumed habitually. The estimates for the Dutch and Scottish subjects average some 0.6, 0.7 and 0.5 g/d using the fatty acid composition of plasma triglyceride, cholesterylester and phospholipid data, respectively. For the French subjects the trans a-linolenic acid intake is estimated to be in the order of 0.2 ± 0.4g/d. However, these approximations depend on small concentrations of trans a-linolenic acid, which are determined with relatively large analytical errors. We also assume a linear relation between intake and incorporation into plasma lipid fractions. This is not entirely the case, as certain trans a-linolenic acid isomers are not incorporated into the cholesterol ester fraction (see Figure 2) . Nevertheless the similarity in estimates based on plasma triglyceride, cholesterol ester and phospholipid composition suggests that they are a reasonable ®rst estimate.
One word of caution is necessary. Our volunteers were recruited from a panel of volunteers in Clermont-Ferrand and from an advertising campaign in Maastricht and in Edinburgh. Obviously they were`self-selected' and do not represent a random population sample. Therefore, the levels of trans fatty acids in these volunteers do not necessarily re¯ect those of the French, Dutch and Scottish populations with great accuracy. Nevertheless the results are in line with those of the Transfair project which speci®cally examined dietary intake of trans fatty acids in European populations by analysing the trans fatty acid content in up to 100 food samples representative of the total fat intake of the 14 countries (van Poppel, 1998) .
Effects of a`high' and`low' trans fat diet All volunteers consumed a diet low in trans fatty acids for 6 weeks to decrease the relative amounts of trans fatty acids in plasma lipids (and readily exchangeable tissue pools). Obviously starting from a low baseline would make it easier to demonstrate any putative effect of trans a-linolenic acid. The question is whether our run-in period was long enough if we aimed to reduce all trans fatty acids, in particular trans 18 : 1. Interestingly the reduced level of trans 18 : 1 in plasma triglycerides and cholesteryl esters did not fall signi®cantly further in the group that continued with the`low' trans diet for another 6 weeks and the levels of these eighteen carbon trans isomers in phospholipids were not in¯uenced by the`low' trans diet at all. Perhaps some of these trans isomers originated from adipose tissue. Another source might be biscuits (prepared with partially hydrogenated oils) consumed by the subjects. It is possible that despite our careful instructions our volunteers did continue to consume, perhaps unwittingly trans fatty acids. Indeed our dietary analyses in Edinburgh men where the intake of trans 18 : 1 could be assessed support the view that this may have been so and only in a study conducted under strict metabolic ward conditions would one be able to obtain perfect compliance. It must be remembered that some partners of these volunteers actually prepared the food. As this was expected, free food was also offered to the entire family to prevent inadvertently mixing of our experimental oils and fats with similar products kept in the household. The volunteers were actively encouraged to discard or return all other fats and oils at the start of each dietary period.
Whatever the reason for the relatively steady C18 : 1 trans levels after the six week run-in period, the biological effects in our study are not affected by changes in C18 : 1 trans. Trans isomers of 20 : 5 did also not change further in the group consuming`low' trans. Thus their production was close to a steady state.
Our dietary record also documented that the amount of trans a-linolenic acid consumed was on average close to what was intended. What was surprising was that the group consuming a`low' trans diet tended to increase the intake of dietary fat, whereas the opposite was true for the`high' trans group. The difference was signi®cant and can affect the outcome of our study. It is well known that a saturated fat diet increases total cholesterol and a fatty diet can raise high density cholesterol (Knuiman et al, 1987; Katan et al, 1994) . However statistical analysis of covariance can easily adjust for this unexplained ®nding.
An important aspect is the dose of trans a-linolenic acid we used. Some 40 % of the total dietary linolenic acid was in the trans form, close to highest values observed in human milk samples from a large Canadian study (Chen et al, 1995) . On that basis it may appear that our study tested rather an extreme dietary amount of trans a-linolenic acid. However, the amount is still within the range that can be observed in the free-living population. The level in human milk samples could be misleading if there is a marked discrimination against trans a-linolenic acid during the absorption and incorporation into milk and perhaps also into lipids. The second and third part of this EC project will address this metabolic issue.
Our data already shows that after 6 weeks on a diet rich in trans a-linolenic acid isomers, there was an increase in these trans isomers as well as that of trans eicosapentaenoic acid in all plasma lipid classes. These results con®rm that the conversion of 15trans a-linolenic to a trans isomer of eicosapentaenoic acid is not restricted to the rat (Grandgirard et al, 1989) . Most interestingly, while the different trans isomers were incorporated into plasma triglycerides and phospholipids, only the 15trans a-linolenic acid was detected in plasma cholesteryl esters. A similar preferential incorporation of this trans isomer into cardiolipin, a phospholipid rich in linoleic acid, suggests that this trans isomer containing 3 carbon-carbon double bonds, is recognised as linoleic acid . Preferential incorporation of 15trans a-linolenic acid into plasma cholesteryl esters could be due to a higher af®nity of lecithin cholesterol acyl transferase (LCAT) for this than for the other trans isomers. It is well known that this enzyme selectively transfers linoleic acid from lecithin to cholesterol (Jonas et al, 1986) . The fatty acid composition of plasma cholesteryl esters and/or phospholipids are used as a marker of compliance of fatty acid intake (De Genes et al, 1980; Gustafson et al, 1983; Blaton et al, 1984; Moilanen et al, 1985; Zock et al, 1997) . Our data suggest that caution should be The TransLinE study JL Se Âbe Âdio et al taken because of the selectivity of LCAT. Interestingly, these trans isomers do not appear to be incorporated into plasma lipids at the expense of a-linolenic acid, illustrated by the fact that the total content of a-linolenic acid (cis trans) remains constant irrespective of whether volunteers were consuming a`low' or`high' trans diet. Also the amount of C18 monounsaturated trans in plasma phospholipids (unlike in triglycerides and cholesteryl esters) did not decline in volunteers consuming a diet low in these trans isomers for 12 weeks altogether. Our results do not support the view that trans a-linolenic acid inhibits the activity of D6 desaturation of linoleic acid, since there were no changes in the composition of n-6 polyunsaturated fatty acids in plasma lipids. However this indirect index of D6 desaturation has been criticised previously. The conversion of stable isotope labelled linoleic acid in volunteers consuming alternatively a diet`low' and`high' in trans a-linolenic acid will be examined.
In conclusion, trans isomers are absorbed from the diet, incorporated in plasma lipids and some trans isomers are converted to long-chain polyunsaturated fatty acids. The study of the effects of these trans fatty acids on risk factors for coronary heart disease in humans is in progress and will be reported shortly.
